As the Ebola epidemic continues to claim lives in West Africa, the scientists are trying to find a cure and believe that virus' deceptively simple structure is a key to taming it.
According to an article in Chemical and Engineering News, the weekly newsmagazine of the American Chemical Society, the scientists are undertaking multiple strategies, some of which are being fast-tracked for human testing to find that key.
Senior editors Lisa M. Jarvis and Bethany Halford noted that the Ebola virus is endowed with a mere seven genes that code for eight proteins and although few in number, the proteins each have many functions, which allow the virus to commandeer nearly 70 proteins from a person it infects.
They said that to fight this highly efficient virus, scientists are taking several approaches, designing antibodies to prevent the virus from attaching to host cells, working on small molecules to attack the virus at various stages of its life cycle and are also starting clinical trials on antiviral drugs that are already approved to treat other kinds of infections.
If developed quickly enough, an effective treatment could curb the current outbreak. It could also potentially spare the world from future epidemics. But as some scientists point out, drugs and vaccines take years to tailor into safe and effective therapies, so it's essential the efforts continue long after this crisis passes.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
